Insight Briefs
View AllBuilding a Successful Clinical Oversight Function: Lessons Learned and Best Practices
In this insight brief, learn how clinical oversight can be carried out in-house by companies that have the necessary time, expertise, and resources to execute and manage the oversight process for all their trials. Alternatively, sponsors will also learn how a clinical oversight function can be executed by an experienced partner through an FSP model.
Read MoreVirtualizing Clinical Trials
Examine the learnings from the pandemic, including case studies of successful use of virtual approaches to run more agile and adaptive trials.
Read MoreIndustry Publications and Presentations
View AllLessons Learned from COVID-19: Why CROs Must Continue Modeling Support and Compassion to Clinical Sites
The COVID pandemic has taught us that compassion is an important attribute that should be modeled amongst clinical research partners and sites to optimize business results. Learn why.
Read MoreDecentralised Clinical Trials in Europe: Lessons from a Pandemic
Author: Graham Belgrave, SVP of European Operations at Advanced Clinical. Since the onset of the COVID-19 pandemic, DCTs have been critical to advancing clinical research by minimising in-person interactions. Benefits include the potential to improve recruitment, facilitate data collection, and reduce the need for travel by patients and CRAs alike, resulting in efficiencies and continued profitability. DCTs demand new roles and partnerships which will likely continue long after the pandemic comes under control. Read our feature article in the Journal of Clinical Studies to learn more.
Read MoreWebinars
View AllShifting Roles in Decentralized Trials (DCT) to Accelerate Clinical Research During the Pandemic and Beyond
In this webcast we explore the changing roles played by sponsors, CROs, site staff, and other stakeholders in DCTs - and how to ensure patients still get the support they need in these virtual research environments.
Read MoreVirtualizing Clinical Trials in a Pandemic: Lessons Learned and What It Means to the Future of R&D
In this webcast we explore how the required adoption of virtual recruiting, telemedicine, remote monitoring and at-home healthcare visits have taught us valuable lessons about how to run more agile and adaptive trials; and how these learnings will shape the future of R&D.
Read MoreCase Studies
View AllAdvanced Clinical | Strategic Resourcing
Learn how our Strategic Resourcing team built a clinical operations solution for a small biotech company with the goal of correcting inefficiencies and keeping business moving forward on time and within budget.
Read MoreAdvanced Clinical Achieves a Strategic Advantage with Veeva Vault eTMF
Learn how we modernize clinical trials by leveraging Veeva’s eTMF cloud solution to run faster, higher-quality trials for study partners.
Read MoreWhitepapers
View AllAchieving Inspection Ready TMF Quality: The Four Cornerstones
Learn how to attain Trial Master File (TMF) Quality sufficient to withstand health authority inspection by thoughtful and deliberate management of four key TMF cornerstones.
Learn MoreImplementing ICH E6 (R2) and Planning for E6 (R3)
This white paper describes lessons learned during the organizational implementation of E6 (R2) at Advanced Clinical, examining operational hurdles, solutions & results.
Read MoreFact Sheets
View AllMedical Writing Capabilities to Deliver a Better Clinical Experience
Learn how our team of medical writing professionals will deliver a better clinical experience.
Read MoreHematology-Oncology Solutions to Deliver a Better Clinical Experience
Learn how we can support your hematology-oncology research.
Read MoreVideos
View AllOne-on-One with Taren Grom: PharmaVOICE
Jason Casarella discusses with PharmaVOICE recent trends in clinical research for 2021 and beyond in this video feature.
Watch NowVirtual Panel: Improving Health Equity Through Diversified Clinical Trials
In Collaboration with PharmaVOICE. The pandemic has further illuminated the need for greater inclusivity of different patient subpopulations as part of clinical development, the result of which would create improved health outcomes and improve health equity. However, to reach these lofty goals, there has be a coordinated strategy that works for all of the key stakeholders: patients, sponsors, CROs, investigators, and sites. A panel of clinical research experts will present ideas for creating a diversified clinical trial plan to improve your chances for success.
Watch Now